Skip to content

Effect of Garlic on Inflammatory Mediators

Effect of Garlic Oil Macerate on Inflammatory Mediators in Healthy Normal Weight and Obese Subjects.

Status
Suspended
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00275405
Enrollment
34
Registered
2006-01-12
Start date
2006-04-30
Completion date
2007-03-31
Last updated
2007-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Effects of Garlic

Brief summary

This research will investigate the effect of garlic oil extract when added to daily diet on inflammatory mediators and blood clotting activation.

Detailed description

To investigate the pharmacokinetics of one of the garlic oil macerate, Ajoene, the anti-inflammatory effect of garlic oil macerate on the pro-inflammatory transcription factor NF-kB, it's activating proteins, including IkB, IkB Kinases a and B (IKKa and IKKB) and the pro-inflammatory NF-kB-regulated proteins, c-reactive protein (CRP), tumor necrosis factor-alpha (TNF-a), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), matrix metalloproteinase-9 (MMP-9), plasminogen activated protein-1 (PAI-1)and the effect of garlic oil macerate intake on platelet activation in normal subjects.

Interventions

DRUGGarlic Oil Macerate

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age and older * Normal subjects with BMI \<25, obese subjects with BMI \>30 * Subjects who have consented to adhere to the diet, regular weekly visits, and blood draws.

Exclusion criteria

* Subjects on any antioxidant medication. * Patient on non-steroidal anti-inflammatory drug. * On any agent with antioxidant properties. * History of drug or alcohol abuse. * Any life threatening disease. * On any agent with significant antioxidant properties. * Taking garlic extracts in the diet regularly.

Design outcomes

Primary

MeasureTime frame
1. To examine the pharmacokinetics of the garlic oil macerate.

Secondary

MeasureTime frame
2. To examine the effect of garlic oil macerate on inflammatory mechanisms at the cellular and molecular level.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026